性别肯定手术后跨性别个体心理健康治疗利用减少:一项全人群研究
该研究基于瑞典全人口登记数据(N=9,747,324),分析2005—2015年确诊性别不一致的2679人2015年心理健康治疗情况。结果显示,该群体心境与焦虑障碍就诊、抗抑郁/抗焦虑药处方及自杀未遂后住院风险均显著高于一般人群;开始激素治疗时长与心理健康治疗无显著关联,但距末次性别肯定手术时间越长,心理健康治疗利用越低。
要点
- 性别不一致诊断者心境与焦虑障碍就诊约为一般人群6倍,抗抑郁/抗焦虑药处方超3倍,自杀未遂后住院超6倍。
- 开始激素治疗时长与心理健康治疗利用无显著关联(aOR=1.01,95%CI 0.98–1.03)。
- 距末次性别肯定手术时间越长,心理健康治疗利用越低(aOR=0.92,95%CI 0.87–0.98)。
核心结论
- 在首个基于全人群的性别不一致诊断跨性别个体研究中,性别肯定手术与后续心理健康治疗利用减少存在纵向关联,支持为有需求的跨性别个体提供性别肯定手术。
研究设计与样本
- 本研究使用瑞典全人口登记(N=9,747,324),链接国家患者登记与处方药登记。
- 分析2005—2015年确诊性别不一致(易性症或性别认同障碍)的2679人,2015年心理健康治疗作为距激素与手术治疗时长的函数。
主要发现
- 与一般人群相比,性别不一致诊断者心境与焦虑障碍就诊约6倍、抗抑郁/抗焦虑药处方超3倍、自杀未遂后住院超6倍。
- 开始激素治疗年数与心理健康治疗可能性无显著相关(aOR=1.01,95%CI 0.98–1.03)。
- 距末次性别肯定手术时间增加与心理健康治疗减少相关(aOR=0.92,95%CI 0.87–0.98)。
关键数值与推荐
- 结局指标包括心境与焦虑障碍就诊、抗抑郁与抗焦虑药处方、自杀未遂后住院。
- 激素治疗时长与心理健康治疗关联的aOR=1.01(95%CI 0.98–1.03)。
- 距末次性别肯定手术时间与心理健康治疗关联的aOR=0.92(95%CI 0.87–0.98)。
临床怎么用
- 临床可参考该人群心境与焦虑障碍就诊、抗抑郁/抗焦虑药处方及自杀未遂后住院风险显著高于一般人群的发现,加强心理健康监测。
- 对于寻求性别肯定手术的跨性别个体,该研究结果支持提供手术的决策,但需结合个体情况综合评估。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Despite professional recommendations to consider gender-affirming hormone and surgical interventions for transgender individuals experiencing gender incongruence, the long-term effect of such interventions on mental health is largely unknown. The aim of this study was to ascertain the prevalence of mood and anxiety disorder health care visits and antidepressant and anxiolytic prescriptions in 2015 as a function of gender incongruence diagnosis and gender-affirming hormone and surgical treatment in the entire Swedish population. METHODS: This study used the Swedish Total Population Register (N=9,747,324), linked to the National Patient Register and the Prescribed Drug Register. Among individuals who received a diagnosis of gender incongruence (i.e., transsexualism or gender identity disorder) between 2005 and 2015 (N=2,679), mental health treatment in 2015 was examined as a function of length of time since gender-affirming hormone and surgical treatment. Outcome measures were mood and anxiety disorder health care visits, antidepressant and anxiolytic prescriptions, and hospitalization after a suicide attempt. RESULTS: Compared with the general population, individuals with a gender incongruence diagnosis were about six times as likely to have had a mood and anxiety disorder health care visit, more than three times as likely to have received prescriptions for antidepressants and anxiolytics, and more than six times as likely to have been hospitalized after a suicide attempt. Years since initiating hormone treatment was not significantly related to likelihood of mental health treatment (adjusted odds ratio=1.01, 95% CI=0.98, 1.03). However, increased time since last gender-affirming surgery was associated with reduced mental health treatment (adjusted odds ratio=0.92, 95% CI=0.87, 0.98). CONCLUSIONS: In this first total population study of transgender individuals with a gender incongruence diagnosis, the longitudinal association between gender-affirming surgery and reduced likelihood of mental health treatment lends support to the decision to provide gender-affirming surgeries to transgender individuals who seek them.
引用
- Bränström R, Pachankis JE. Reduction in Mental Health Treatment Utilization Among Transgender Individuals After Gender-Affirming Surgeries: A Total Population Study. Am J Psychiatry. 2019. PMID: 31581798. doi:10.1176/appi.ajp.2019.19010080
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。